Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10

Pedro M M C Machado; Robert B M Landewé; Désirée M van der Heijde

doi:10.3899/jrheum.110279

Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10

J Rheumatol. 2011 Jul;38(7):1502-6. doi: 10.3899/jrheum.110279.

Authors

Pedro M M C Machado¹, Robert B M Landewé, Désirée M van der Heijde

Affiliation

¹ Department of Rheumatology, Coimbra University Hospital, Coimbra, Portugal.

PMID: 21724723
DOI: 10.3899/jrheum.110279

Abstract

The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess disease activity in ankylosing spondylitis (AS). Criteria for disease activity states and improvement scores are important for use in clinical practice, observational studies, and clinical trials, and have been proposed by the Assessment of SpondyloArthritis international Society (ASAS). At OMERACT 10, our aim was to obtain endorsement from OMERACT for the ASDAS disease activity states and response criteria proposed by the ASAS membership. This article summarizes the associated discussions, the scientific basis of the validation process, and the results from the voting sessions, and identifies areas for research using the ASDAS. OMERACT participants agreed with the selection of cutoff values, which now have the combined endorsement of ASAS and OMERACT and are ready to be used in clinical practice and in research settings.

Publication types

Consensus Development Conference
Research Support, Non-U.S. Gov't

MeSH terms

Disability Evaluation*
Humans
Outcome Assessment, Health Care / methods*
Reproducibility of Results
Severity of Illness Index*
Spondylitis, Ankylosing / therapy*
Surveys and Questionnaires
Treatment Outcome